acurxpharma.com - ACXP Net Assets per Single Share

Graphic logo of Acurx Pharmaceuticals, Inc. (ACXP)

Acurx Pharmaceuticals (ACXP) demonstrates potential through the development of innovative treatments against resistant bacteria. The book value per common share visualizes capital dynamics, where 1.74 forms the current metric value. The model relies on low production costs coupled with high patent leverage. Management's lean approach to research is aimed at securing major strategic partners.

Acurx (ACXP): Share Book Value from 07/04/2022 to 10/27/2026

Acurx Pharmaceuticals Inc. - analytical breakdowns and key metrics (ACXP)

- price and consensus price forecast:
Stock Quotes Acurx|ACXP - Broker Consensus Forecast
- market capitalization data:
Market Value Acurx Pharmaceuticals, Inc.|ACXP - Full Business Value
- book capitalization data:
Net Assets per Single Share Acurx Pharmaceuticals|ACXP - Net Asset Value|Market Capitalization to Book Value Ratio acurxpharma.com|ACXP - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Acurx Pharmaceuticals|ACXP - Long-Term Debt to Capital|Short-Term Debt to Equity Acurx|ACXP - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Acurx Pharmaceuticals, Inc.
Fundamental company valuation:acurxpharma.com - ACXP
Manufactured products of Acurx

Book value per share reflects the portion of net assets attributable to a single security, allowing for an assessment of the real value of capital net of liabilities. By analyzing the book value per share chart, an investor can track the trend of dilution or consolidation of stakes, which is critical for Acurx Pharmaceuticals (ACXP), as its antibiotic development costs—subject to economic standards—directly impact residual capital.

Competitors of Acurx Pharmaceuticals (ACXP)

Armata Pharma (ARMP) - Accounting Value per Share